-
1
المؤلفون: Jignesh P. Patel, Roopen Arya, Lara N. Roberts, R. K. Patel, First Registry Investigators, Vicky Speed
المصدر: Thrombosis Research. 197:16-19
مصطلحات موضوعية: medicine.medical_specialty, Rivaroxaban, medicine.drug_mechanism_of_action, business.industry, Factor Xa Inhibitor, MEDLINE, Anticoagulants, Venous Thromboembolism, Hematology, medicine.disease, Obesity, United Kingdom, medicine, Humans, Registries, Intensive care medicine, business, Venous thromboembolism, Factor Xa Inhibitors, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18ca24fd96fd2d6584a1bc2308e45f09Test
https://doi.org/10.1016/j.thromres.2020.10.021Test -
2
المؤلفون: Emma Gee, Gabrielle Saul, R. K. Patel, Catherine Rea, Julia Czuprynska, Roopen Arya, Raj K. Patel, Alison Brown, Bipin Vadher, Rosalind Byrne, Vicky Speed, Lara N. Roberts, Jignesh P. Patel, Evelyn Coles
المصدر: Thrombosis Research
مصطلحات موضوعية: Counseling, medicine.medical_specialty, Pyridines, Administration, Oral, Disease, Thrombophilia, medicine.disease_cause, Hospitals, University, Tertiary Care Centers, Patient Education as Topic, Rivaroxaban, Internal medicine, London, Pandemic, Epidemiology, medicine, Humans, Pandemics, Coronavirus, Informed Consent, Drug Substitution, SARS-CoV-2, business.industry, Warfarin, Anticoagulants, COVID-19, Hematology, Patient Acceptance of Health Care, medicine.disease, Telemedicine, Thiazoles, Quarantine, Oral anticoagulant, Drug Monitoring, business, Coagulation and Fibrinolysis, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64ab6c08e9fddab6e6474df893d44d33Test
https://doi.org/10.1016/j.thromres.2020.11.004Test -
3
المؤلفون: Bruce Green, Anna Gazes, Alison Brown, Jignesh P. Patel, Emma Gee, John K. Bartoli-Abdou, Julia Czuprynska, Roopen Arya, Raj K. Patel, Valerie Scott, Sarah Woolcombe, Lara N. Roberts, Sinead Duffy, Victoria Speed, Sarah Barsam, R. K. Patel, Bipin Vadher, Rosalind Byrne
المصدر: Speed, V, Green, B, Roberts, L N, Woolcombe, S, Bartoli-abdou, J, Barsam, S, Byrne, R, Gee, E, Czuprynska, J, Brown, A, Duffy, S, Vadher, B, Patel, R, Scott, V, Gazes, A, Patel, R K, Arya, R & Patel, J P 2020, ' Fixed dose rivaroxaban can be used in extremes of bodyweight: a population pharmacokinetic analysis ', Journal of Thrombosis and Haemostasis, vol. 18, no. 9, pp. 2296-2307 . https://doi.org/10.1111/jth.14948Test
مصطلحات موضوعية: medicine.medical_specialty, anticoagulants, Population, Renal function, 030204 cardiovascular system & hematology, Fixed dose, Body Mass Index, 03 medical and health sciences, body weight, 0302 clinical medicine, Pharmacokinetics, Rivaroxaban, Internal medicine, medicine, Humans, In patient, education, rivaroxaban, Blood Coagulation, drug monitoring, education.field_of_study, business.industry, Anticoagulants, Hematology, Pharmacokinetic analysis, Obesity, Morbid, business, Body mass index, pharmacokinetics, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e435a19d261d37c15fc8a56cb63dc524Test
https://pubmed.ncbi.nlm.nih.gov/33650251Test